-Pharma CEO’s should not be evaluated on the company’s stock price alone.
-When Wall Street wins patients usually lose.
-Mr Merck was right, putting patients first will lead to profits.
-Pharma CEO’s should not be evaluated on the company’s stock price alone.
-When Wall Street wins patients usually lose.
-Mr Merck was right, putting patients first will lead to profits.
KEY SUMMARY: Fobres, in a recent editorial, said “Pharma Needs A Leader In 2016” and I couldn’t agree more, but let’s be honest here, most pharma CEO’s are NOT leaders but rather high paid executives who bow to investor needs and demands.